The Use of Lavender vs Vanilla Essential Oil as Complementary Analgesia for Frenotomy in Healthy Newborns (LVEO-SME1)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04867824 |
|
Recruitment Status :
Not yet recruiting
First Posted : April 30, 2021
Last Update Posted : April 30, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Ankyloglossia | Dietary Supplement: Case (use of inhaled vanilla essential oil) Dietary Supplement: Control (use of inhaled lavender essential oil) | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 142 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Supportive Care |
| Official Title: | Comparison of Lavender vs Vanilla Essential Oil as Complementary Analgesia for Frenotomy in Healthy Newborns: a Randomized Clinical Trial. |
| Estimated Study Start Date : | May 10, 2021 |
| Estimated Primary Completion Date : | December 9, 2021 |
| Estimated Study Completion Date : | December 31, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Control
The neonate will be taken to the neonatal unit and monitored with a pulse-oximeter before, during and after the procedure. We will swaddle it, will administer 1 mL of oral sucrose, let the newborn suck for 2 minutes prior to the procedure, and will have a 7 x 7 cm gauze pad with 1 drop of 100% pure LEO (Pranarôm España S.L.) placed 2 cm under the nose for 2 minutes prior to starting the frenotomy and during the procedure.
|
Dietary Supplement: Control (use of inhaled lavender essential oil)
Use of inhaled lavender essential oil during frenotomy for a tongue-tie |
|
Experimental: Case
The neonate will be taken to the neonatal unit and monitored with a pulse-oximeter before, during and after the procedure. We will swaddle it, will administer 1 mL of oral sucrose, let the newborn suck for 2 minutes prior to the procedure, and will have a 7 x 7 cm gauze pad with 1 drop of 100% pure vanilla essential oil (Pranarôm España S.L.) placed 2 cm under the nose for 2 minutes prior to starting the frenotomy and during the procedure.
|
Dietary Supplement: Case (use of inhaled vanilla essential oil)
Use of inhaled vanilla essential oil during frenotomy for a tongue-tie |
- Crying length [ Time Frame: Up to 5 minutes post-procedure ]Crying length after the frenotomy in seconds
- NIPS score [ Time Frame: Up to 5 minutes post-procedure ]Neonatal Infant Pain Score value (0-7). NIPS evaluates facial expression, crying, breathing pattern, arm and leg position, and state of arousal on a scale from 0 to 7, where 0-2 means no pain to mild pain, 3-4 mild to moderate pain, and >4 severe pain.
- Increase in heart rate [ Time Frame: Up to 5 minutes post-procedure ]Increase in heart rate pre/post-procedure (beats per minute)
- Decrease in oxygen saturation [ Time Frame: Up to 5 minutes post-procedure ]Decrease in oxygen saturation (%)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | up to 15 Days (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Healthy full-term neonates born at Hospital del Mar (Barcelona, Spain), or less than 15 days old who had been discharged and returned for the frenotomy, who underwent a frenotomy for type 3 tongue-ties according to Coryllos classification and the Hazelbaker tool during the study period
Exclusion Criteria:
- Refusal of the patient's parents to participate
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04867824
| Contact: Silvia Maya-Enero, Ph.D., M.D. | +34 93 248 3145 | 62175@parcdesalutmar.cat |
| Principal Investigator: | Silvia Maya-Enero, Ph.D., M.D. | Hospital del Mar |
| Responsible Party: | Parc de Salut Mar |
| ClinicalTrials.gov Identifier: | NCT04867824 |
| Other Study ID Numbers: |
2021/9731/I |
| First Posted: | April 30, 2021 Key Record Dates |
| Last Update Posted: | April 30, 2021 |
| Last Verified: | April 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
ankyloglossia tongue-tie aromatherapy lavender |
vanilla pain neonate frenotomy |
|
Ankyloglossia Stomatognathic Diseases |

